A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Testosterone Cypionate (AZMIRO)

Androgen class · 10 generic manufacturers · 16 ANDAs filed at FDA.

First FDA approval1979-07-25
Generic availableYes · 10 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$61.3M in CY2024 Part D spend1.7M claims · 529K beneficiaries · 329 plans surveyed

Lowest NADAC
$1.88/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$6.01
Across all dosage forms in distribution.
Highest NADAC
$11.45
Wide spread — brand-strength NDCs still in market.
Plans with PA
816 / 329
Substantial PA friction across plans.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Testosterone Cypionate used for?

Testosterone Cypionate is a Androgen medication tracked in Medicare Part D.

Is there a generic for Testosterone Cypionate?

Yes. 16 ANDAs filed at FDA, 10 generic manufacturers currently shipping.

How much does my plan pay for Testosterone Cypionate?

Across 329 Part D plans, Testosterone Cypionate averages $6.01/unit (NADAC). Lowest available: $1.88/unit. Highest in distribution: $11.45/unit.

Is Testosterone Cypionate on the FDA shortage list?

No. Testosterone Cypionate is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Androgen6 alternatives in D1
01
Danazol
Androgen
$1.56Lowest NADAC
2Generic mfrs
$2.8MCY24 Part D spend
Compare →
02
Esterified Estrogens and Methyltestosterone
Brand: Estratest FS
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Esterified Estrogens, Methyltestosterone
Brand: ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Methyltestosterone
Brand: METHITEST
Lowest NADAC
2Generic mfrs
$917,715CY24 Part D spend
Compare →
05
Testosterone
Brand: AndroGel
$0.442Lowest NADAC
14Generic mfrs
$145.9MCY24 Part D spend
Compare →
06
Testosterone Gel,
Androgen
$0.504Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.